Journal Articles
Wijker, Naomi E., Vidmar, Suzanna, Grimwood, Keith, Sly, Peter D., Byrnes, Catherine A., Carlin, John B., Cooper, Peter J., Robertson, Colin F., Massie, R. John, Kemner van de Corput, Mariette P. C., Cheney, Joyce, Tiddens, Harm A.W.M. and Wainwright, Claire E. (2020) Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort. European Respiratory Journal, 1901694. doi:10.1183/13993003.01694-2019
Moodie, Marj, Lal, Anita, Vidmar, Suzanna, Armstrong, David S., Byrnes, Catherine A., Carlin, John B., Cheney, Joyce, Cooper, Peter J., Grimwood, Keith, Robertson, Colin F., Tiddens, Harm A. and Wainwright, Claire E. (2014) Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis. Journal of Pediatrics, 165 3: 564-569.e5. doi:10.1016/j.jpeds.2014.05.031
Knibbs, Luke D., Johnson, Graham R., Kidd, Timothy J., Cheney, Joyce, Grimwood, Keith, Kattenbelt, Jacqueline A., O'Rourke, Peter K., Ramsay, Kay A., Sly, Peter D., Wainwright, Claire E., Wood, Michelle E., Morawska, Lidia and Bell, Scott C. (2014) Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis. Thorax, 69 8: 740-745. doi:10.1136/thoraxjnl-2014-205213
Hennig, Stefanie, McKay, Karen, Vidmar, Suzanna, O'Brien, Katie, Stacey, Sonya, Cheney, Joyce and Wainwright, Claire E. (2014) Safety of inhaled (TOBI(R)) and intravenous tobramycin in young children with cystic fibrosis. Journal of Cystic Fibrosis, 13 4: 428-434. doi:10.1016/j.jcf.2014.01.014
Byrnes, Catherine Ann, Vidmar, Suzanna, Cheney, Joyce L., Carlin, John B., Armstrong, David S., Cooper, Peter J., Grimwood, Keith, Moodie, Marj, Robertson, Colin F., Rosenfeld, Margaret, Tiddens, Harm A. and Wainwright, Claire E. (2013) Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax, 68 7: 643-651. doi:10.1136/thoraxjnl-2012-202342
Hu, H., Harmer, C., Anuj, S., Wainwright, C. E., Manos, J., Cheney, J., Harbour, C., Zablotska, I., Turnbull, L., Whitchurch, C. B., Grimwood, K., Rose, B. and ACFBAL study investigators (2013) Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening. Clinical Microbiology and Infection, 19 3: 266-272. doi:10.1111/j.1469-0691.2012.03770.x
Manos J., Hu H., Rose B.R., Wainwright C.E., Zablotska I.B., Cheney J., Turnbull L., Whitchurch C.B., Grimwood K., Harmer C., Anuj S.N. and Harbour C. (2013) Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis. European Journal of Clinical Microbiology and Infectious Diseases, 32 12: 1583-1592. doi:10.1007/s10096-013-1916-7
Wainwright, Claire E., Vidmar, Suzanna, Armstrong, David S., Byrnes, Catherine A., Carlin, John B., Cheney, Joyce, Cooper, Peter J., Grimwood, Keith, Moodie, Marj, Robertson, Colin F. and Tiddens, Harm A. (2011) Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: A randomized trial. JAMA: Journal of the American Medical Association, 306 2: 163-171. doi:10.1001/jama.2011.954
Cheney, Joyce, Barber, Scott, Altamirano,Luis, Cheney, Marise, Williams, Chris, Jackson, Mary, Yates, Patsy, O'Rourke, Peter and Wainwright, Claire (2005) A clinical pathway for bronchiolitis is effective in reducing readmission rates. The Journal of Pediatrics, 147 5: 622-626. doi:10.1016/j.jpeds.2005.06.040
Redmann, S, Wainwright, C, Stacey, S, Champion, A, Mitchell, P, Cheney, J and Charles, B (2005) Misleading high tobramycin plasma concentrations can be caused by skin contamination of fingerprick blood following inhalation of nebulized tobramycin (TOBI (R)) - A short report. Therapeutic Drug Monitoring, 27 2: 205-207. doi:10.1097/01.ftd.0000155341.16361.62
Wainwright, C., Altamirano, L., Cheney, M., Cheney, J., Barber, S., Price, D. A., Moloney, S. E., Kimberley, A., Woolfield, N., Cadzow, S., Fiumara, F., Wilson, P., Mego, S., VandeVelde, D. and Sanders, S. L. (2003) A multicentre, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. New England Journal of Medicine, 349 1: 27-35. doi:10.1056/NEJMoa022226
Conference Papers
Roehrer, Erin, Cummings, Elizabeth, Turner, Paul, Hauser, Jenny, Cameron-Tucker, Helen, Beggs, Sean A., Micallef, Nicole A., Wainwright, Claire, Cheney, Joyce, Jessup, Mel, Saddington, Heather, Ellis, Leonie, Walters, Haydn and Reid, David W. (2013). Supporting cystic fibrosis with ICT. In: Enabling health and healthcare through ICT: available, tailored and closer. ITCH 2013, Laurel Point, Victoria, BC, Canada, (137-141). 21-23 February 2013. doi:10.3233/978-1-61499-203-5-137
Byrnes, C. A., Vidmar, S., Cheney, J. and Wainwright, C. E. (2012). Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age (for ACFBAL Study Group). In: 26th Annual North American Cystic Fibrosis Conference, Orlando, FL, United States, (352-352). 11-13 October 2012. doi:10.1002/ppul.22682
He Hu, Anuj S, Claire Wainwright, Whitechurch C, Harmer C, Joyce Cheney, Turnbull L, Manos J, Keith Grimwood, Bye P, Rose B and and the ACFBAL study investigators (2011). Environmental origins of Pseudomanos aeruginosa in children with cystic fibrosis. In: 13th International Conference on Pseudomonas, Sydney , Australia, (). 4-7th September 2011.
He Hu, Rose B, Claire Wainwright, Whitechurch C, Elkins M, Bye P, Harmer C, Joyce Cheney, Turnbull L, Keith Grimwood, Manos J and and the ACFBAL study investigators (2011). Loss of virulence expression of pseudomonas aeruginosa from cystic fibrosis lung infection over time. In: 13th International Conference on Pseudomonas, Sydney , Australia, (). 4-7 September 2011.
Redmann, S., Stacey, S., Champion, A., Wainwright, C. E., Mitchell, P., Cheney, J. and Charles, B. G. (2004). Misleading high tobramycin plasma concentrations due to dermal contamination on fingers after inhalation of nebulised tobramycin (TOBI). In: Building a healthier future through research. 4th Annual Queensland Health and Medical Scientific Meeting, Brisbane, (264-264). 30 November - 1 December, 2004.